Collegium Pharmaceutical, Inc. Increase (Decrease) in Accounts Receivable
Collegium Pharmaceutical, Inc. (COLL) reported Increase (Decrease) in Accounts Receivable of $15.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$2.13M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $17.43M, a 10155.29% increase year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$22.62M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $20.93M, a 10913.68% increase year-over-year.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$17.20M, a 489.76% decline from fiscal 2024.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $4.41M.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$3.59M, a 116.50% decline from fiscal 2022.
- Collegium Pharmaceutical, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $21.78M, a 3.30% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.30M 10-Q · filed 2026-08-06 | -$7.32M derived: sum of 3 quarters · filed 2026-08-06 | $13.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $17.43M 10-Q · filed 2026-05-07 | -$5.19M derived: sum of 2 quarters · filed 2026-05-07 | $15.74M derived: sum of 3 quarters · filed 2026-05-07 | $60.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$22.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.70M derived: sum of 2 quarters · filed 2026-02-26 | -$17.37M derived: sum of 3 quarters · filed 2026-08-06 | -$17.20M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $20.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.25M derived: sum of 2 quarters · filed 2026-08-06 | $5.42M 10-Q · filed 2025-11-06 | $5.31M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$15.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$15.51M 10-Q · filed 2026-08-06 | -$15.62M derived: sum of 3 quarters · filed 2026-08-06 | -$15.43M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $170.00K 10-Q · filed 2026-05-07 | $64.00K derived: sum of 2 quarters · filed 2026-05-07 | $254.00K derived: sum of 3 quarters · filed 2026-05-07 | $9.42M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $84.00K derived: sum of 2 quarters · filed 2026-02-26 | $9.25M derived: sum of 3 quarters · filed 2026-02-26 | $4.41M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.35M derived: sum of 2 quarters · filed 2025-11-06 | $4.52M 10-Q · filed 2025-11-06 | $2.19M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $9.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $4.33M 10-Q · filed 2025-08-07 | $2.00M derived: sum of 3 quarters · filed 2026-02-26 | $16.38M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$4.83M 10-Q · filed 2025-05-08 | -$7.16M derived: sum of 2 quarters · filed 2026-02-26 | $7.21M derived: sum of 3 quarters · filed 2026-02-26 | -$4.43M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.05M derived: sum of 2 quarters · filed 2026-02-26 | $399.00K derived: sum of 3 quarters · filed 2026-02-26 | -$3.59M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $14.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.73M derived: sum of 2 quarters · filed 2024-11-07 | -$1.27M 10-Q · filed 2024-11-07 | -$13.55M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$11.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$15.64M 10-Q · filed 2024-08-08 | -$27.92M derived: sum of 3 quarters · filed 2025-02-27 | -$30.02M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$3.99M 10-Q · filed 2024-05-09 | -$16.28M derived: sum of 2 quarters · filed 2025-02-27 | -$18.38M derived: sum of 3 quarters · filed 2025-02-27 | $12.78M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$12.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$14.38M derived: sum of 2 quarters · filed 2025-02-27 | $16.77M derived: sum of 3 quarters · filed 2025-02-27 | $21.78M 10-K · filed 2025-02-27 | ||||
| 2022-09-30 | -$2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $29.06M derived: sum of 2 quarters · filed 2023-11-07 | $34.06M 10-Q · filed 2023-11-07 | -$9.09M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $31.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $36.16M 10-Q · filed 2023-08-03 | -$6.99M derived: sum of 3 quarters · filed 2024-02-22 | $51.91M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $5.01M 10-Q · filed 2023-05-04 | -$38.15M derived: sum of 2 quarters · filed 2024-02-22 | $20.75M derived: sum of 3 quarters · filed 2024-02-22 | $17.69M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$43.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $15.75M derived: sum of 2 quarters · filed 2024-02-22 | $12.69M derived: sum of 3 quarters · filed 2024-02-22 | $22.52M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | $58.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $55.84M derived: sum of 2 quarters · filed 2022-11-03 | $65.68M 10-Q · filed 2022-11-03 | $72.53M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $6.78M 10-Q · filed 2022-08-04 | $13.63M derived: sum of 3 quarters · filed 2023-02-23 | $8.90M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $9.84M 10-Q · filed 2022-05-10 | $16.69M derived: sum of 2 quarters · filed 2023-02-23 | $11.96M derived: sum of 3 quarters · filed 2023-02-23 | $7.73M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $6.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $2.13M derived: sum of 2 quarters · filed 2023-02-23 | -$2.11M derived: sum of 3 quarters · filed 2023-02-23 | $10.37M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$8.96M derived: sum of 2 quarters · filed 2021-11-04 | $3.51M 10-Q · filed 2021-11-04 | -$7.91M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$4.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $8.24M 10-Q · filed 2021-08-05 | -$3.19M derived: sum of 3 quarters · filed 2022-02-24 | -$84.00K derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | $12.47M 10-Q · filed 2021-05-06 | $1.05M derived: sum of 2 quarters · filed 2022-02-24 | $4.15M derived: sum of 3 quarters · filed 2022-02-24 | $288.00K derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$8.33M derived: sum of 2 quarters · filed 2022-02-24 | -$12.19M derived: sum of 3 quarters · filed 2022-02-24 | -$4.99M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$759.00K derived: sum of 2 quarters · filed 2020-11-05 | $6.43M 10-Q · filed 2020-11-05 | $18.10M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.33M 10-Q · filed 2020-08-05 | $15.00M derived: sum of 3 quarters · filed 2021-02-25 | $13.15M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $7.19M 10-Q · filed 2020-05-07 | $18.86M derived: sum of 2 quarters · filed 2021-02-25 | $17.01M derived: sum of 3 quarters · filed 2021-02-25 | $19.36M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $11.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.82M derived: sum of 2 quarters · filed 2021-02-25 | $12.16M derived: sum of 3 quarters · filed 2021-02-25 | $68.23M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $497.00K derived: sum of 2 quarters · filed 2019-11-06 | $56.56M 10-Q · filed 2019-11-06 | $60.71M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $58.41M 10-Q · filed 2019-08-07 | $62.56M derived: sum of 3 quarters · filed 2020-02-27 | $63.50M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $56.07M 10-Q · filed 2019-05-08 | $60.21M derived: sum of 2 quarters · filed 2020-02-27 | $61.16M derived: sum of 3 quarters · filed 2020-02-27 | $62.69M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $5.09M derived: sum of 2 quarters · filed 2020-02-27 | $6.62M derived: sum of 3 quarters · filed 2020-02-27 | $7.84M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $946.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $2.47M derived: sum of 2 quarters · filed 2018-11-08 | $3.69M 10-Q · filed 2018-11-08 | $4.14M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $2.75M 10-Q · filed 2018-08-08 | -$2.75M 10-Q · filed 2017-08-09 | $3.20M derived: sum of 3 quarters · filed 2019-02-27 | $7.83M derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2017-03-31 | $1.22M 10-Q · filed 2018-05-09 | -$1.22M 10-Q · filed 2017-05-10 | $1.67M derived: sum of 2 quarters · filed 2019-02-27 | $6.30M derived: sum of 3 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $450.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $5.08M derived: sum of 2 quarters · filed 2019-02-27 | $2.13M 10-K · filed 2019-02-27 | -$2.13M 10-K · filed 2017-03-10 | ||||
| 2016-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.68M 10-Q · filed 2017-11-08 | -$1.68M 10-Q · filed 2016-11-10 | |||||
| 2016-06-30 | -$2.95M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |